SNDX Trial readout: Tuesday, December 1, 2026

EventTrial readout
DateTuesday, December 1, 2026
MarketUS listing
SourceCT.gov registry · confidence 70% · primary source ↗

Est. Completion: 2026-12-01. Status: RECRUITING. Title: A Phase I-II Study Investigating the All-Oral Combination of the Menin Inhibitor SNDX-5613 With Decitabine/Cedazuridine (ASTX727) and Venetoclax in Acute Myeloid Leukemia (SAVE)

Dates are sourced from official registries and filings and can change — estimated dates (marked ~) slip routinely. This page updates automatically when the source registry moves the date. Research information only, not investment advice.

Every date on this page is free — forever.

A free account adds the interactive calendar with US/EU filters and watchlists. Investor (€19/mo) adds Impact Forecasts on each event, date-slip tracking and calendar sync (Google/Apple/Outlook). Pro adds the full analytics stack.